HealthDay

Higher lifetime and last-30-day substance use rates seen, particularly among 8th graders

Improved overall survival versus chemotherapy regardless of the PD-L1 tumor proportion score

No significant difference between regions in median OS for those receiving, not receiving systemic tx

Most frequently reported adverse events included injection site erythema and swelling, pyrexia

Use of updated equations would relabel about 11.8 million high-risk U.S. adults as lower-risk

Adaptive transfer of mutant-protein-specific tumor-infiltrating lymphocytes leads to disease regression

Sunitinib alone noninferior to nephrectomy plus sunitinib with respect to overall survival

Similar efficacy for endocrine, chemoendocrine tx for women with midrange 21-gene recurrence score

And, pre-op chemoradiotherapy linked to longer overall survival than immediate surgery

Here are what the editors at HealthDay consider to be the most important developments in Allergy for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. ASHP: SVP, Injectable Opioid Shortages Threaten Patient Care […]

Here are what the editors at HealthDay consider to be the most important developments in Cardiology for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. No Consistent Cardiovascular Benefit Seen for Supplements THURSDAY, […]

Here are what the editors at HealthDay consider to be the most important developments in Dermatology for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Oral Propranolol Seems Safe for Infantile Hemangioma THURSDAY, […]

Here are what the editors at HealthDay consider to be the most important developments in Family Practice for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. No Consistent Cardiovascular Benefit Seen for Supplements […]

Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. ASHP: SVP, Injectable Opioid Shortages Threaten Patient Care […]

Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. ASHP: SVP, Injectable Opioid Shortages Threaten […]

Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. FDA Issues Final Guidance on Inhalational Anthrax […]

Here are what the editors at HealthDay consider to be the most important developments in Neurology for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. ASHP: SVP, Injectable Opioid Shortages Threaten Patient Care […]

Here are what the editors at HealthDay consider to be the most important developments in OBGYN & Women’s Health for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Variables ID’d to Predict Height […]